Showing results (2071-2080 of 2,171) with videos related to

Sort By:
Pageof 218
Biorxiv : the Preprint Server for Biology|January 3, 2024
ProtPipe: A Multifunctional Data Analysis Pipeline for Proteomics and PeptidomicsZiyi Li, Cory A Weller, Syed Shah, et al.
Stem Cell Reports|July 14, 2023
A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cellsVukasin M Jovanovic, Claire Weber, Jaroslav Slamecka, et al.
Nature Neuroscience|August 11, 2022
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease statesNina M Dräger, Sydney M Sattler, Cindy Tzu-Ling Huang, et al.
The Journal of Experimental Medicine|August 27, 2014
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLDMichael E Ward, Alice Taubes, Robert Chen, et al.
Elife|December 28, 2022
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectorsJoseph M Replogle, Jessica L Bonnar, Angela N Pogson, et al.
Antiviral Therapy|May 4, 2005
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroidsSarah E Ward, Mona R Loutfy, Lawrence M Blatt, et al.
The Lancet. Oncology|November 1, 2020
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji K Kumar, Simon J Harrison, Michele Cavo, et al.
Elife|November 9, 2020
Distinct insulin granule subpopulations implicated in the secretory pathology of diabetes types 1 and 2Alex J B Kreutzberger, Volker Kiessling, Catherine A Doyle, et al.
Journal of Medicinal Chemistry|July 10, 2010
Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulatorSimon E Ward, Mark Harries, Laura Aldegheri, et al.
EMBO Molecular Medicine|November 28, 2012
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosisSahar A Saddoughi, Salih Gencer, Yuri K Peterson, et al.
Pageof 218